Interleukin-28 and hepatitis C virus genotype-4: treatment-induced clearance and liver fibrosis.
about
Genotype 4 HCV infection is difficult to cure with pegylated interferon and ribavirin. Results from a Greek Nationwide Cohort Study.Meta-analysis: influence of host and viral factors in patients with chronic hepatitis C genotype 4 treated with pegylated interferon and ribavirin.IL-28B polymorphisms correlated with treatment response in HCV-4 mono-infected patients: a meta-analysis.Sustained virological response and its treatment predictors in hepatitis C virus genotype 4 compared to genotypes 1, 2, and 3: a meta-analysis.Individualization of chronic hepatitis C treatment according to the host characteristics.The role of pharmacogenetics in the treatment of chronic hepatitis C infection.Interleukin 28B polymorphisms as predictors of sustained virological response in chronic hepatitis C: systematic review and meta-analysis.Distribution of IL28B Polymorphism in a Cohort of Italians and Immigrants with HCV Infection: Association with Viraemia, Stage of Fibrosis and Response to Treatment.New use of an old drug: chloroquine reduces viral and ALT levels in HCV non-responders (a randomized, triple-blind, placebo-controlled pilot trial).Racial disparities in the proportion of current, unresolved hepatitis C virus infections in the United States, 2003-2010.Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4.
P2860
Q33918559-7439D83E-6C5E-49C3-A610-0B00E93F9BB4Q34270336-4A3A7468-B200-4088-BB76-38E425ACFDCDQ35124008-3185F364-61E7-455D-8C86-A581B3535652Q36140466-3E524B9B-41BE-4135-A9C8-D8F226B39DE4Q37654502-C6E56773-BBC5-4FD2-B49A-191F7D803A4CQ38151586-509A3DB0-AEC7-4798-99B2-36FD4D6D0E56Q38445623-093AE3B2-3C1B-4E48-902F-EEB67178E0CAQ40642039-574525FA-9F4A-4C54-9D9B-A87802B642ABQ40747582-5A7CCE3B-C641-41E9-A631-CC0C1A2D31F5Q42235045-C1BECDB6-4293-4C1B-8092-C92507C87104Q42264136-43A04458-4C50-4A17-B6FA-E2CB631B6D37
P2860
Interleukin-28 and hepatitis C virus genotype-4: treatment-induced clearance and liver fibrosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Interleukin-28 and hepatitis C ...... clearance and liver fibrosis.
@ast
Interleukin-28 and hepatitis C ...... clearance and liver fibrosis.
@en
type
label
Interleukin-28 and hepatitis C ...... clearance and liver fibrosis.
@ast
Interleukin-28 and hepatitis C ...... clearance and liver fibrosis.
@en
prefLabel
Interleukin-28 and hepatitis C ...... clearance and liver fibrosis.
@ast
Interleukin-28 and hepatitis C ...... clearance and liver fibrosis.
@en
P2093
P2860
P356
P1476
Interleukin-28 and hepatitis C ...... d clearance and liver fibrosis
@en
P2093
Fatima Shebl
Khaled Alejji
Manik Sharma
Mohammed Butt
Moutaz Derbala
Muneera Almohanadi
Nazeeh Eldweik
Rafie Yaqoob
Saad Alkaabi
P2860
P304
P356
10.3748/WJG.V18.I47.7003
P407
P577
2012-12-01T00:00:00Z